Ariad Pharmaceuticals Inc fka ARIA

[Jesspro]

Iandy, read between the lines of that HB statement.
He's practically signalling the investors that Pona's
potential multiple indications alone not counting
113 and the others on the shelf will propel ARIAD
multiple times its value today. You would be lying to
yourself if you say you would rather did not hear it
at all. That alone is a seed planted in the minds of
these institutional investors. Forget about your
infatuation with BTH. Harvey is the real thing.